TABLE 4

Molecular Breast Cancer Subtype Analysis

Pathologic responseSurvival (mo)
Molecular subtypenpCRNon-pCRSUVmax, PET1ΔSUV1–3DMFSOS
HR-positive/HER2-negative111109.5 ± 3.8−69% ± 1870.294.3
HR-negative/HER2-positive52316.7 ± 5.3−94% ± 1745.878.7
Triple-negative72512.5 ± 7−85% ± 2736.763.7
  • DMFS = distant metastasis-free-survival; OS = overall survival.